Navigate medical device development and commercialization to ensure that you have human and financial resources to ensure successful US launches.
As regulatory and logistical barriers to digital undertakings lessen, eMarketing is growing more prevalent in pharma. The digital space unlocks great potential for companies to expand market reach. New online channels, including social media and mobile technology, are finding their way within each company’s marketing media mix.
Prepare promotional speaker program teams for the Sunshine Act by refocusing events on medical messages, adapting speaker bureaus, fine-tuning event management and recruiting speakers.
Explore in-depth mobile health (mHealth) data including mobile team structures, usage of mHealth initiatives, best practices and 10 mobile application case studies.
Explore detailed commercialization spending benchmarks for 15 brands to know when and how much to invest in specific areas of advertising and promotion, market access, decision support and medical affairs.
Develop the internal resources and strategy to engage patients, build consumer relationships and drive improved outcomes.
Understand ROI benchmarks, set your marketing mix and drive brand sales.
Form lasting patient relationships with patient-focused communications tools, strong educational standards and meaningful ROI.
Prepare for drug launch by tracking budget and staffing data for 16 brands from Phase III through post-launch.
Launch your drug in the US with detailed benchmarks for advertising and promotion, medical affairs, market access and more.
Boost meeting attendance and address tough compliance issues while addressing demands from internal and external clients.
Track IVDs’ commercial development with data on investment benchmarks, marketing organizations, reimbursement support and sales forces.
Build customer relationship management skills to manage data and communications across the organization.
Boost your projects’ commercial potential with early spending data for 14 brands' resources from pre-clinical through Phase 2.
Explore brand marketing budgets in seven affiliate markets — including developed and emerging economies.
Track 9 brands through their first three years of annual spending in advertising, promotion, market access and decision support.
Drive years of blockbuster returns with smart investment and strategic planning that eliminates the hurdles facing any high-profile brand.
Push sub-blockbuster brands as far as possible with detailed resource benchmarks from development through post-launch.
Harness resource data to support the development and launch of specialty/niche brands within global, US and European groups.
Benchmark marketing resources from development through post-launch with brand data at the pan-European and affiliate levels.
Set commercialization and launch resources for oncology drugs using benchmarks for a range of critical variables.